Clinical Research Directory

Inclusion Criteria: 1. Patients are clinically diagnosed as primary aldosteronism with ARR≥37 (PAC showed as pg/ml, renin showed as μIU/mL) and passed through PA confirmatory tests (PAC-post CCT\>110pg/ml, PAC-post SSIT \>80pg/ml, or PAC-post FST\>60pg/ml). PAC: plasma aldosterone concentration; 2. Patients with willing for AVS; 3. Age 18 or above, male or female, with legal capacity. Exclusion Criteria: 1. Patients with suspected adrenocortical carcinoma or pheochromocytoma; 2. Patients with high risk of adrenal surgery; 3. Patients have been subtyping to glucocorticoid-suppressible hyperaldosteronism or familial hyperaldosteronism type III; 4. Patients were diagnosed as Cushing syndrome or subclinical Cushing syndrome; 5. Patients were treated with glucocorticoids recently; 6. Patients with whole body or venipuncture area infection; 7. Patients with venous access thrombosis; 8. Patients are allergic to iodine; 9. Patients with X-ray contraindications; 10. Patients with coagulation dysfunction; 11. Patients are unable to cooperate and follow-up.